PEG-MGF: 2mg
Muscle developmentDescription
Peg-mgf (pegylated mechano growth factor) is a chemically modified version of mgf in which polyethylene glycol molecules are attached to the peptide structure through pegylation. this single modification solves mgf's primary limitation — extending the half-life from 5-7 minutes to several hours or days, allowing twice-weekly rather than daily dosing and enabling the peptide to remain in circulation long enough to exert meaningful systemic effects. peg-mgf works by activating muscle satellite cells — the stem-like progenitor cells responsible for muscle repair and hypertrophy — stimulating their proliferation and delaying premature differentiation, thereby expanding the pool of repair cells available after training-induced microtrauma. research has also demonstrated anti-apoptotic effects in cardiac myocytes, bone defect healing via osteoblast proliferation (1.4x greater effect than igf-1 in one study), and cartilage protection. because pegylation distributes the peptide systemically rather than locally, peg-mgf can be injected subcutaneously rather than requiring intramuscular injection into specific muscle groups. commonly studied alongside igf1-lr3 in a complementary protocol: peg-mgf post-workout for repair signaling, igf1-lr3 on rest days for growth. for research and educational purposes only.
Specifications
| Amount in Vial | 2mg |
|---|---|
| BAC Water | 2ml |
| Amount per Unit | 0.01mg per unit |
| Recommended Dose | 200mcg to 400mcg (20 to 40 units) |
| Frequency | 2 to 3 times per week |
| Injection Type | Subcutaneous |
| Timing | Post-workout administration. 5-6 week cycles. Stack with IGF1-LR3 on alternating days. |
Dose Calculator
Based on 0.01mg per unit (100-unit insulin syringe)
Quick Reference
Reconstitution
Vial size: 2mg
Add BAC water: 2ml
Concentration: 0.01mg per unit
For research and educational use only.
This page provides research dosing information only. Not intended as medical advice. Consult a qualified professional before any use.